Company overview
USCC
913306007258898636
Id2
330600400010566
English Name
Zhejiang Guobang Pharmaceutical Co., Ltd.
Former names
浙江国邦兽药有限公司, 浙江国邦应用化工有限公司
Chinese Name
浙江国邦药业有限公司
Entity type
Limited Liability Company (Sole Legal-Person Ownership, Non-Natural Person)
Authorized capital
¥13,880
Phone
+8657582738278
Representative
姚礼高
Establishment date
6 August 2004
Country
China
Primary goods traded
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 April 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011759-Bd-709 Dt: 15/03/2022) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $1,344,000.00 | |
| 19 July 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $892,500.00 | |
| 29 November 2022 | NG | 2941900000 | Ciprofloxacin Hcl Usp43 | Sagar Overseas Limited | NG | Zhejiang Guobang Pharmaceutical Company Limited | $764,777.55 | |
| 4 April 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-005870-Bd-709 Dt: 08/04/2020) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $640,833.33 | |
| 21 April 2022 | IN | 29415000 | Azithromycin Amine | Kopran Research Laboratories Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $624,493.84 | |
| 9 May 2022 | IN | 29415000 | Azithromycin Amine | Kopran Research Laboratories Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $612,000.00 | |
| 29 March 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $580,500.00 | |
| 26 July 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280 Bd-709 Dt: 28/10/21) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $452,200.00 | |
| 30 September 2022 | IN | 29415000 | Azithromycin Usp /Ip (Form 10 No: Il/Bd-011280-Bd-709 Dt: 28/10/2021) | Cipla Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $446,250.00 | |
| 28 November 2018 | IN | 29419090 | Azithromycin Amine | Wockhardt Limited | IN | Zhejiang Guobang Pharmaceutical Company Limited | $430,500.00 |
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Tigaka Distrindo Perkasa | buyer | $7,758,853 | 25.08% |
| PT Megasetia Agung Kimia | buyer | $1,759,455 | 5.69% |
| PT Kimia Farma | buyer | $1,495,275 | 4.83% |
| PT Dilimas Mandiri | buyer | $726,152 | 2.35% |
| Wockhardt Limited | buyer | $489,500 | 1.58% |
| PT Dexa Medica | buyer | $474,456 | 1.53% |